Summary:
- This article discusses a new technology that uses mRNA to deliver therapeutic payloads directly to the brain, bypassing the blood-brain barrier.
- The technology, developed by researchers at the University of California, San Diego, involves encapsulating mRNA in lipid nanoparticles that can cross the blood-brain barrier and deliver the mRNA to target cells in the brain.
- This approach has the potential to treat a wide range of neurological and psychiatric disorders by allowing for the targeted delivery of therapeutic proteins or other molecules to specific regions of the brain.